Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Reprod Health Matters ; 22(44 Suppl 1): 125-33, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25702076

ABSTRACT

The majority of abortions in Colombia continue to take place outside the formal health system under a range of conditions, with the majority of women obtaining misoprostol from a thriving black market for the drug and self-administering the medication. We conducted a cost analysis to compare the costs to the health system of three approaches to the provision of abortion care in Colombia: post-abortion care for complications of unsafe abortions, and for legal abortions in a health facility, misoprostol-only medical abortion and vacuum aspiration abortion. Hospital billing records from three institutions, two large maternity hospitals and one specialist reproductive health clinic, were analysed for procedure and complication rates, and costs by diagnosis. The majority of visits (94%) were to the two hospitals for post-abortion care; the other 6% were for legal abortions. Only one minor complication was found among the women having legal abortions, a complication rate of less than 1%. Among the women presenting for post-abortion care, 5% had complications during their treatment, mainly from infection or haemorrhage. Legal abortions were associated not only with far fewer complications for women, but also lower costs for the health system than for post-abortion care. We calculated based on our findings that for every 1,000 women receiving post-abortion care instead of a legal abortion within the health system, 16 women experienced avoidable complications, and the health system spent US $48,000 managing them. Increasing women's access to safe abortion care would not only reduce complications for women, but would also be a cost-saving strategy for the health system.


Subject(s)
Abortion, Induced , Abortion, Legal , Health Care Costs , Abortifacient Agents, Nonsteroidal/therapeutic use , Abortion, Induced/economics , Abortion, Induced/methods , Abortion, Induced/statistics & numerical data , Abortion, Legal/economics , Abortion, Legal/methods , Abortion, Legal/statistics & numerical data , Adult , Ambulatory Care Facilities , Colombia , Decision Support Techniques , Female , Health Care Costs/statistics & numerical data , Health Care Reform , Hospitals, Maternity , Humans , Misoprostol/therapeutic use , Pregnancy , Vacuum Curettage , Women's Health
SELECTION OF CITATIONS
SEARCH DETAIL
...